อ้างอิง ของ เมแทมเฟตามีน

  1. ↑ United States Congress Senate Committee on the Judiciary Subcommittee to Investigate Juvenile Delinquincy (1 January 1972). Amphetamine legislation 1971: Hearings, Ninety-second Congress, first session, pursuant to S. Res. 32, section 12, investigation of juvenile delinquency in the United States (PDF). U.S. Govt. Print. Off. p. 161. สืบค้นเมื่อ 1 January 2016. We made a decision in January of 1969 to cease the manufacture of injectable methamphetamines.
  2. 1 2 Rau T, Ziemniak J, Poulsen D (2015). "The neuroprotective potential of low-dose methamphetamine in preclinical models of stroke and traumatic brain injury". Prog. Neuropsychopharmacol. Biol. Psychiatry. 64: 231–6. doi:10.1016/j.pnpbp.2015.02.013. PMID 25724762. In humans, the oral bioavailability of methamphetamine is approximately 70% but increases to 100% following intravenous (IV) delivery (Ares-Santos et al., 2013).
  3. ↑ "Toxicity". Methamphetamine. PubChem Compound. National Center for Biotechnology Information. สืบค้นเมื่อ 31 December 2013.
  4. ↑ "Adderall XR Prescribing Information" (PDF). United States Food and Drug Administration. December 2013. pp. 12–13. สืบค้นเมื่อ 30 December 2013.
  5. ↑ Krueger SK, Williams DE (June 2005). "Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism". Pharmacol. Ther. 106 (3): 357–387. doi:10.1016/j.pharmthera.2005.01.001. PMC 1828602. PMID 15922018.
  6. 1 2 Riviello, Ralph J. (2010). Manual of forensic emergency medicine : a guide for clinicians. Sudbury, Mass.: Jones and Bartlett Publishers. p. 41. ISBN 9780763744625.
  7. 1 2 3 Schep LJ, Slaughter RJ, Beasley DM (August 2010). "The clinical toxicology of metamfetamine". Clinical Toxicology (Philadelphia, Pa.). 48 (7): 675–694. doi:10.3109/15563650.2010.516752. ISSN 1556-3650. PMID 20849327.
  8. ↑ "Properties: Predicted – EP|Suite". Methmphetamine. Chemspider. สืบค้นเมื่อ 3 January 2013.
  9. ↑ "Chemical and Physical Properties". Methamphetamine. PubChem Compound. National Center for Biotechnology Information. สืบค้นเมื่อ 31 December 2013.
  10. ↑ "Desoxyn Prescribing Information" (PDF). United States Food and Drug Administration. December 2013. สืบค้นเมื่อ 6 January 2014.
  11. ↑ Westfall DP, Westfall TC (2010). "Miscellaneous Sympathomimetic Agonists". In Brunton LL, Chabner BA, Knollmann BC. Goodman & Gilman's Pharmacological Basis of Therapeutics (12th ed.). New York: McGraw-Hill. ISBN 978-0-07-162442-8.

แหล่งที่มา

WikiPedia: เมแทมเฟตามีน http://www.accessmedicine.com/content.aspx?aID=166... http://www.chemspider.com/Chemical-Structure.1169.... http://www.accessdata.fda.gov/drugsatfda_docs/labe... http://www.accessdata.fda.gov/drugsatfda_docs/labe... //www.ncbi.nlm.nih.gov/pmc/articles/PMC1828602 //www.ncbi.nlm.nih.gov/pubmed/15922018 //www.ncbi.nlm.nih.gov/pubmed/20849327 //www.ncbi.nlm.nih.gov/pubmed/25724762 http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs... http://www.kegg.jp/entry/D08187